Slide One
Slide Two
Slide Three

Latest News

July 16, 2015

Protagonist Therapeutics Raises $40 Million Series C Financing to Advance Oral Peptide Drugs into Clinical Development

December 4, 2014

Protagonist Therapeutics Closes 2nd Tranche of $18 Million Series B for Advancing Development Candidate to Clinical Trials in 2015

November 5, 2014

Protagonist Therapeutics Elects Chaitan Khosla, Ph.D. to Board of Directors

Upcoming Events

BioEurope 2015 – 21st Annual International Partnering Conference

November 2-4, 2015
Munich, Germany

2015 Advances in IBD – Crohn’s & Colitis Foundation’s Clinical & Research Conference

December 10-12, 2015
Orlando, Florida